Melissa M. Rhodes, MD

Melissa M. Rhodes, MD, is the Director of the Comprehensive Sickle Cell and Thalassemia Program at Nationwide Children’s Hospital and an Assistant Professor of Pediatrics at The Ohio State University College of Medicine. Her research interests include cardiopulmonary complications, nutrition and growth and development in sickle cell disease. She is also interested in the interactions between developing red blood cells and other cell types in various forms of anemia. Dr. Rhodes is the institutional investigator for national trials in sickle cell disease, including membership in the National Institutes of Health Sickle Cell Disease Clinical Trials Network.

Gender:

• Female

Languages Spoken:

• English

Medical School

• Eastern Virginia Medical School
  Date Completed: 05/31/1999

Residency

• Children's Hospital of the King's Daughters Hospit
  Date Completed: 06/30/2002

Fellowship

• Vanderbilt University School of Medicine
  Date Completed: 06/30/2006

Department:

• Pediatrics

Section:

• Hematology/Oncology

Speciality:

• Pediatric Hematology Oncology
  
• Pediatrics
  

Date of Appointment at Nationwide Children’s Hospital:

• 07/01/2008

• Koury,Mark,J; Rhodes,Melissa. 2012. How to approach chronic anemia.  Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. Vol. 2012, no. January: 183-190.
• Dickerson AK, Klima J, Rhodes MM, O’Brien S. 2011. Young adults with SCD in U.S. children’s hospitals: are they different from adolescents?.  Pediatr Blood Cancer.
• Rhodes M, Ashford L, Manes B, Calder C, Domm J, Frangoul H. 2011. Bone marrow transplant in phosphoglycerate kinase deficiency.  British Journal of Haematology. Vol. 152, no. January: 500-502.
• Bollinger LM, Nire KG, Rhodes MM, Chisholm DJ, O'Brien SH. 2011. Caregivers perspectives on barriers to transcranial doppler screening in children with sickle cell disease.  Pediatric Blood and Cancer.
• Debaun MR, Sarnaik SA, Rodeghier MJ, Minniti CP, Howard TH, Iyer RV, Inusa B, Telfer PT, Kirby-Allen M, Quinn CT, Bernaudin F, Airewele G, Woods GM, Panepinto JA, Fuh B, Kwiatkowski JK, King AA, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Sabio H, Gonzalez CE, Saccente SL, Kalinyak KA, Strouse JJ, Fixler JM, Gordon MO, Miller JP, Ichord RN, Casella JF. 2011. Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, gender and relative high systolic blood pressure.  Blood.
• Poehling K, Simms L, Rhodes M, Snively B, Halasa N, Mitchel E, Schaffner W, Craig A, Griffin M. 2010. Sickle cell trait, hemoglobin C trait and invasive pneumococcal disease.  Epidemiology. Vol. 3, no. 21. (January): 340-346.
• Rhodes M, Akohoue S, Shankar S, Flemming I, An A, Yu C, Acra S, Buchowski M. 2009. Growth patterns in children with sickle cell anemia during puberty.  Pediatric Blood and Cancer. Vol. 53, no. January: 635-641.
• Koury MJ, Mahmud N, Rhodes MM. 2009. Origin and Development of Blood Cells. In Wintrobe’s Clinical Hematology, 12th ed.. 12 ed. Edited by John Greer. New York, NY: LWW.
• O’Keeffe E, Rhodes M, Woodworth A. 2009. To C or not to C—Interesting diagnostic challenges of hemoglobinopathies.  Clinical Chemistry. Vol. 55, no. January: 1228-1233.
• Rhodes M, Kopsombut P, Bondurant M, Price J, Koury M. 2008. Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin.  Blood.
• Rhodes M, Miller J, Sipos L, Whitlock J. 2007. ChemoDuck: the creation of an educational tool for young children with cancer.  Supportive and Palliative Cancer Care. Vol. 4, no. 4. (January): 13-16.
• Flanagan J, Rhodes M, Beutler E. 2006. The identification of a recurrent Phosphoglycerate Kinase mutation associated with chronic hemolytic anemia and neurological dysfunction in a family from the USA.  British Journal of Hematology.
• Rhodes M, Delbeke D, Whitlock J, Martin W, Kuttesch J, Frangoul H, Shankar S. 2006. Utility of FDG-PET in follow-up of children treated for Hodgkin’s Non-Hodgkin’s Lymphoma.  Journal of Pediatric Hematology and Oncology.
• Rhodes M, Kopsombut P, Bondurant M, Price J, Koury M. 2005. Bcl-xL prevents apoptosis of late-stage erythroblasts but does not mediate the anti-apoptotic effects of erythropoietin.  Blood.
• Guthrie SO, Rhodes M, Janco R, Stein SM, Jabs K, Engelhardt B. 2005. An infant with Kasabach-Merritt syndrome with associated renal hematoma and intussusception.  Journal of Perinatology.
• Rhodes M, Lautz T, Kavanaugh-Mchugh A, Manes B, Calder C, Koyama T, Liske M, Parra D, Frangoul H. 2005. Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients.  Bone Marrow Transplant.